<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Autolus_Therapeutics_plc</id>
	<title>Autolus Therapeutics plc - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Autolus_Therapeutics_plc"/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Autolus_Therapeutics_plc&amp;action=history"/>
	<updated>2026-04-25T06:38:27Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=Autolus_Therapeutics_plc&amp;diff=408029&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei Autolus Therapeutics plc listata cu simbolul US.AUTL  ==Descriere companie== Autolus Therapeutics plc (www.autolus.com) is a clinical-stage biopharmaceutical company. The Company is focused on developing programmed T cell therapies for the treatment of cancer. The Company has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. Its lead clinical programs include AUTO1 (obecabtagene autoleuc...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Autolus_Therapeutics_plc&amp;diff=408029&amp;oldid=prev"/>
		<updated>2024-09-18T13:40:11Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei Autolus Therapeutics plc listata cu simbolul US.AUTL  ==Descriere companie== Autolus Therapeutics plc (www.autolus.com) is a clinical-stage biopharmaceutical company. The Company is focused on developing programmed T cell therapies for the treatment of cancer. The Company has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. Its lead clinical programs include AUTO1 (obecabtagene autoleuc...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei Autolus Therapeutics plc listata cu simbolul US.AUTL&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Autolus Therapeutics plc (www.autolus.com) is a clinical-stage biopharmaceutical company. The Company is focused on developing programmed T cell therapies for the treatment of cancer. The Company has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. Its lead clinical programs include AUTO1 (obecabtagene autoleucel, Obe-Cel), AUTO4, and AUTO6 / AUTO6NG. Obe-cel is a CD19 CAR T cell investigational therapy designed to overcome limitations in clinical activity and safety. Obe-cel reduces toxicity and is less prone to T cell exhaustion, which could improve persistence and the ability of programmed T cells to engage in serial killing of target cancer cells. AUTO4 is a T cell therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1. AUTO6 / AUTO6NG is a T cell therapy targeting GD2 in development for the treatment of neuroblastoma. Its other clinical programs include AUTO5, AUTO7, and AUTO8.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.AUTL&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre Autolus Therapeutics plc (US.AUTL)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.AUTL&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.AUTL]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>